<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02085902</url>
  </required_header>
  <id_info>
    <org_study_id>CHD 079-13</org_study_id>
    <nct_id>NCT02085902</nct_id>
  </id_info>
  <brief_title>Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery?</brief_title>
  <acronym>VesiRop</acronym>
  <official_title>Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Departemental Vendee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Departemental Vendee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since the recommendations of the French Society of Digestive Surgery 2010, cholecystectomy
      can be performed as outpatient surgery. This approach is difficult in many centers because of
      post operative pain and nausea/vomiting.

      The use of postoperative morphine may be responsible for the state of nausea. The use of
      ropivacaine allows a reduction of the morphine consumption and thus may allow the patient to
      have their surgery as an outpatient.

      Currently, ropivacaine is used randomly during the investigators surgeries. Initially, it was
      used for the infiltration holes trocar. In recent years, ropivacaine is used for the
      reduction of intra-abdominal postoperative pain. Its use is made of parietal surgery ( hernia
      ) in cholecystectomy and colonic surgery. This mode of administration is allowed to view the
      many publications made on this subject. Its use in the investigators daily surgery, however,
      has not been evaluated in ambulatory surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to discharge patient after surgery</measure>
    <time_frame>6 hours postoperative</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Cholecystectomy</condition>
  <condition>Laparoscopy</condition>
  <arm_group>
    <arm_group_label>standard anesthesia</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>standard anesthesia with ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ropivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <arm_group_label>standard anesthesia with ropivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Programmed Cholecystectomy

          -  Laparoscopy

          -  Man and woman

          -  ≥ 18

          -  ASA 1 or 2

          -  Not living alone

          -  Patient receiving social security coverage

          -  Signature of Informed Consent Form

        Exclusion Criteria:

          -  Cholecystectomy emergency

          -  Patient minor

          -  Pregnant woman (pregnancy test) or during breastfeeding

          -  Conversion to laparotomy

          -  Patient anticoagulant curative dose

          -  Living alone

          -  Patient addict

          -  Peptic Ulcer

          -  Refusal to enter the protocol

          -  Chronic requiring analgesics long-term

          -  Immunosuppression

          -  Long-term Treatment with corticosteroids

          -  Discovery intraoperative calculation in the bile duct

          -  Contraindication to ropivacaine (see cons-indications to ropivacaine)

          -  Hypersensitivity to study treatment or concomitant medications anesthesia

          -  Cardiac or unbalanced epileptic patients (due to the risk of cardiovascular and
             neurological local anesthetics)

          -  Patients ASA ≥ 3

          -  Patient &lt;50 kg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emeric ABET, Dr</last_name>
    <role>Study Director</role>
    <affiliation>CHD Vendée La Roche sur Yon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalier départemental Vendée</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2014</study_first_submitted>
  <study_first_submitted_qc>March 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2014</study_first_posted>
  <last_update_submitted>May 18, 2015</last_update_submitted>
  <last_update_submitted_qc>May 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

